Skip to main navigation

Investors
News
- News Releases
- News and Mentions
Presentations & Events
- Presentations
- Events
Stock Performance
- Stock Information
- Analyst Coverage
Financials & Filings
- SEC Filings
- Quarterly Results
Corporate Governance
Resources

News Releases

Year

Nov 12 / 24

Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Nov 05 / 24

Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results

Nov 03 / 24

Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds

Oct 14 / 24

Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting

Oct 08 / 24

Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual Summit

Sep 10 / 24

Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease

Sep 03 / 24

Belite Bio to Participate in Three Upcoming Investor Conferences

Sep 01 / 24

Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer

Aug 09 / 24

Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Displaying 1 - 9 of 32

Belite Bio™ Inc
12750 High Bluff Drive Suite 475,
San Diego CA, 92130 USA

Join our mailing list.

Sign up to receive important updates and news from Belite Bio